Co-Delivery of Polymeric Metformin and Cisplatin by Self-Assembled Core-Membrane Nanoparticles to Treat Non-Small Cell Lung Cancer

Journal of Controlled Release - Netherlands
doi 10.1016/j.jconrel.2016.11.005
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Metformin Enhances the Radiosensitizing Effect of Cisplatin in Non-Small Cell Lung Cancer Cell Lines With Different Cisplatin Sensitivities

Scientific Reports
Multidisciplinary
2019English

Cisplatin, Vinblastine, and Bleomycin in Inoperable Non-Small Cell Lung Cancer.

Thorax
PulmonaryRespiratory Medicine
1985English

MicroRNA-182 Modulates Chemosensitivity of Human Non-Small Cell Lung Cancer to Cisplatin by Targeting PDCD4

Diagnostic Pathology
Forensic MedicineMedicinePathologyHistology
2014English

Epigenetic Activation of FOXF1 Confers Cancer Stem Cell Properties to Cisplatin‑resistant Non‑small Cell Lung Cancer

International Journal of Oncology
Cancer ResearchOncology
2020English

Refractory Non-Small-Cell Lung Cancer Responding to Combination Chemotherapy With Gemcitabine and Cisplatin

Japanese Journal of Lung Cancer
OncologyRespiratory MedicinePulmonary
2003English

RPV‐modified Epirubicin and Dioscin Co‐delivery Liposomes Suppress Non‐small Cell Lung Cancer Growth by Limiting Nutrition Supply

Cancer Science
Cancer ResearchMedicineOncology
2020English

Cerium Oxide Nanoparticles Sensitize Non-Small Lung Cancer Cell to Ionizing Radiation

Marmara Pharmaceutical Journal
2018English

New Basic Approach to Treat Non-Small Cell Lung Cancer Based on RNA-interference

Thoracic Cancer
MedicinePulmonaryRespiratory MedicineOncology
2014English

Association of ATP7A Expression and in Vitro Sensitivity to Cisplatin in Non-Small Cell Lung Cancer

Oncology Letters
Cancer ResearchOncology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy